Channels and Transporters as Drug Targets
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Chemical Biology".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 7151
Special Issue Editors
Interests: drug targets; molecular pharmacology; biomarkers; redox; metabolism
Special Issue Information
Dear Colleagues,
As the guest editors of a timely, topical and high-quality collection titled “Channels and Transporters as Drug Targets” in Molecules, we are delighted to announce this exciting initiative, and we are particularly encouraging “Channels and Transporters as Drug Targets” in all areas of pharmacology and chemical biology around the world to take part. Channels and transporters typically consist of biomolecules that play key roles in a large variety of physiological and pathological processes. Importantly, many links to human diseases have been established, such as links to cardiovascular diseases, cancer, neurodegenerative diseases, immune diseases, infectious diseases or metabolic diseases, and channels and transporters as novel and promising therapeutic approaches for these diseases have been proposed. This collection will bring together the latest high-quality contributions to channels and transporters as drug targets.
The aim of this Special Issue is to publish original papers and reviews dealing with the recent developments in the field of channels and transporters as drug targets. We very much look forward to your contributions.
Dr. Hongsheng Zhang
Dr. Zhe Zhou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug targets
- channels
- transporters
- targeted therapy
- pharmacology
- novel therapy
- biomarkers
- prognostic marker
- precision medicine
- drug discovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
